Redcare Pharmacy (RDC) Stock Forecast & Price Target

Compare

57 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RDC Analyst Ratings

Moderate Buy

6 Buy

0 Hold

1 Sell

Based on 7 analysts giving stock ratings to

Redcare

Pharmacy

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RDC Stock 12 Month Forecast

Average Price Target

€151.43

▲(141.71% Upside)

Based on 7 Wall Street analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is €151.43 with a high forecast of €214.00 and a low forecast of €82.00. The average price target represents a 141.71% change from the last price of €62.65.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"63":"€63","101":"€101","139":"€139","177":"€177","215":"€215"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":214,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€214.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":151.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€151.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€82.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[63,101,139,177,215],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.7,76.18461538461538,87.66923076923078,99.15384615384616,110.63846153846154,122.12307692307692,133.60769230769233,145.0923076923077,156.5769230769231,168.06153846153848,179.54615384615386,191.03076923076924,202.51538461538462,{"y":214,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.7,71.37153846153846,78.04307692307692,84.71461538461539,91.38615384615385,98.05769230769232,104.72923076923078,111.40076923076924,118.0723076923077,124.74384615384616,131.41538461538462,138.08692307692309,144.75846153846155,{"y":151.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,64.7,66.03076923076924,67.36153846153846,68.6923076923077,70.02307692307693,71.35384615384615,72.68461538461538,74.01538461538462,75.34615384615384,76.67692307692307,78.00769230769231,79.33846153846153,80.66923076923077,{"y":82,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":150,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.7,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116.9,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€214.00

Average Price Target€151.43

Lowest Price Target€82.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Sven Sauer

Kepler Capital

€144

Buy

129.85%

Upside

Reiterated

12/03/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gerhard Orgonas

Berenberg Bank

€165

Buy

163.37%

Upside

Reiterated

11/05/25

Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Sarah Roberts

Barclays

€140→€130

Buy

107.50%

Upside

Reiterated

10/30/25

Redcare Pharmacy (0RJT) Gets a Buy from Barclays

Jan Koch

Deutsche Bank

€214

Buy

241.58%

Upside

Reiterated

10/30/25

Deutsche Bank Keeps Their Buy Rating on Redcare Pharmacy (0RJT)

Olivier Calvet

UBS

€82

Sell

30.89%

Upside

Reiterated

10/29/25

UBS Remains a Sell on Redcare Pharmacy (0RJT)

Martin Comtesse

Jefferies

€150

Buy

139.43%

Upside

Reiterated

10/29/25

Positive Financial Performance and Growth Prospects Justify Buy Rating for Redcare Pharmacy

Volker Bosse

Baader Bank

€175

Buy

179.33%

Upside

Reiterated

10/29/25

Redcare Pharmacy (0RJT) Gets a Buy from Baader Bank

Christian Salis

Hauck & Aufhaeuser

€175→€170

Buy

171.35%

Upside

Reiterated

05/07/25

Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Yannik Siering

Stifel Nicolaus

€190

Buy

203.27%

Upside

Reiterated

04/04/25

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Aisyah Noor

Morgan Stanley

€140→€147

Hold

134.64%

Upside

Reiterated

03/12/25

Redcare Pharmacy NV (RDC:GR) PT Raised to EUR147 at Morgan StanleyMorgan Stanley analyst Aisyah Noor raised the price target on Redcare Pharmacy NV (RDC:GR) to EUR147.00 (from EUR140.00) while maintaining a Equalweight rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Sven Sauer

Kepler Capital

€144

Buy

129.85%

Upside

Reiterated

12/03/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Gerhard Orgonas

Berenberg Bank

€165

Buy

163.37%

Upside

Reiterated

11/05/25

Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Sarah Roberts

Barclays

€140→€130

Buy

107.50%

Upside

Reiterated

10/30/25

Redcare Pharmacy (0RJT) Gets a Buy from Barclays

Jan Koch

Deutsche Bank

€214

Buy

241.58%

Upside

Reiterated

10/30/25

Deutsche Bank Keeps Their Buy Rating on Redcare Pharmacy (0RJT)

Olivier Calvet

UBS

€82

Sell

30.89%

Upside

Reiterated

10/29/25

UBS Remains a Sell on Redcare Pharmacy (0RJT)

Martin Comtesse

Jefferies

€150

Buy

139.43%

Upside

Reiterated

10/29/25

Positive Financial Performance and Growth Prospects Justify Buy Rating for Redcare Pharmacy

Volker Bosse

Baader Bank

€175

Buy

179.33%

Upside

Reiterated

10/29/25

Redcare Pharmacy (0RJT) Gets a Buy from Baader Bank

Christian Salis

Hauck & Aufhaeuser

€175→€170

Buy

171.35%

Upside

Reiterated

05/07/25

Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)

Yannik Siering

Stifel Nicolaus

€190

Buy

203.27%

Upside

Reiterated

04/04/25

Strong Customer Growth and Margin Improvement Justify Buy Rating for Redcare Pharmacy

Aisyah Noor

Morgan Stanley

€140→€147

Hold

134.64%

Upside

Reiterated

03/12/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Redcare Pharmacy

1 Month

xxx

Success Rate

21/32 ratings generated profit

Average Return

+7.02%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 65.63% of your transactions generating a profit, with an average return of +7.02% per trade.

3 Months

xxx

Success Rate

23/32 ratings generated profit

Average Return

+20.44%

reiterated a xxx

rating 7 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +20.44% per trade.

1 Year

Olivier CalvetUBS

Success Rate

33/40 ratings generated profit

Average Return

+44.27%

reiterated a sell rating 2 months ago

Copying Olivier Calvet's trades and holding each position for 1 Year would result in 82.50% of your transactions generating a profit, with an average return of +44.27% per trade.

2 Years

xxx

Success Rate

37/40 ratings generated profit

Average Return

+73.65%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 92.50% of your transactions generating a profit, with an average return of +73.65% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RDC Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RDC has received 15 Buy Ratings, 4 Hold Ratings, and 2 Sell Ratings. RDC average Analyst price target in the past 3 months is 151.43.

Each month's total comprises the sum of three months' worth of ratings.

RDC Financial Forecast

RDC Earnings Forecast

Next quarter’s earnings estimate for RDC is -€0.83 with a range of -€0.83 to -€0.83. The previous quarter’s EPS was -€0.36. RDC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year RDC has Performed in-line its overall industry.

RDC Sales Forecast

Next quarter’s sales forecast for RDC is €817.33M with a range of €810.00M to €822.30M. The previous quarter’s sales results were €719.23M. RDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year RDC has Performed in-line its overall industry.

RDC Stock Forecast FAQ

What is DE:RDC’s average 12-month price target, according to analysts?

Based on analyst ratings, Redcare Pharmacy’s 12-month average price target is 151.43.

What is DE:RDC’s upside potential, based on the analysts’ average price target?

Redcare Pharmacy has 141.71% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Redcare Pharmacy a Buy, Sell or Hold?

Redcare Pharmacy has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 0 hold ratings and 1 sell ratings.

What is Redcare Pharmacy’s share price target?

The average share price target for Redcare Pharmacy is 151.43. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €214.00 ,and the lowest forecast is €82.00. The average share price target represents 141.71% Increase from the current price of €62.65.

What do analysts say about Redcare Pharmacy?

Redcare Pharmacy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.

How can I buy shares of Redcare Pharmacy?

To buy shares of DE:RDC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Redcare Pharmacy (RDC) Stock Forecast & Price Target

RDC Analyst Ratings

RDC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Redcare Pharmacy

RDC Analyst Recommendation Trends

RDC Financial Forecast

RDC Earnings Forecast

RDC Sales Forecast

RDC Stock Forecast FAQ

Detailed List of Analyst Forecasts